| scholarly article | Q13442814 |
| P2093 | author name string | S J Wilson | |
| J C Boyer | |||
| L L Estabrooks | |||
| W K Kaufmann | |||
| P2860 | cites work | Checkpoints: controls that ensure the order of cell cycle events | Q28131705 |
| Role of DNA topoisomerase I in the transcription of supercoiled rRNA gene | Q28577043 | ||
| Roles of DNA topoisomerases in simian virus 40 DNA replication in vitro | Q34595603 | ||
| DNA topoisomerase II mutant of Saccharomyces cerevisiae: topoisomerase II is required for segregation of daughter molecules at the termination of DNA replication | Q36258619 | ||
| Radiosensitivity in ataxia-telangiectasia: a new explanation | Q36419108 | ||
| New data on clonal anomalies of chromosome 14 in ataxia telangiectasia: tct(14;14) and inv(14). | Q36492229 | ||
| Topoisomerase inhibitors can selectively interfere with different stages of simian virus 40 DNA replication | Q36901211 | ||
| In situ localization of DNA topoisomerase II, a major polypeptide component of the Drosophila nuclear matrix fraction | Q37691913 | ||
| Inhibition and recovery of DNA synthesis in human cells after exposure to ultraviolet light | Q38521196 | ||
| Cell death, chromosome damage and mitotic delay in normal human, ataxia telangiectasia and retinoblastoma fibroblasts after x-irradiation | Q38524035 | ||
| Effect of caffeine on DNA synthesis in irradiated and unirradiated mammalian cells | Q38524424 | ||
| Formation of nascent DNA molecules during inhibition of replicon initiation in mammalian cells | Q38526532 | ||
| Pathways of human cell post-replication repair | Q38596913 | ||
| DNA topoisomerases as targets for chemotherapy | Q39211064 | ||
| Mechanism of action of antitumor drug etoposide: a review | Q39290578 | ||
| Inhibition of p34cdc2 kinase activity by etoposide or irradiation as a mechanism of G2 arrest in Chinese hamster ovary cells | Q41730782 | ||
| Proliferation-dependent regulation of DNA topoisomerase II in cultured human cells. | Q42803837 | ||
| A defect in DNA topoisomerase II activity in ataxia-telangiectasia cells | Q42817261 | ||
| Molecular analysis of a t(7;14)(q35;q32) chromosome translocation in a T cell leukemia of a patient with ataxia telangiectasia | Q44450500 | ||
| Effects of the epipodophyllotoxin VP-16-213 on cell cycle traverse, DNA synthesis, and DNA strand size in cultures of human leukemic lymphoblasts. | Q47255834 | ||
| Studies on camptothecin. I. Effects of nucleic acid and protein synthesis | Q47727975 | ||
| Effect of cell proliferation and chromatin conformation on intercalator-induced, protein-associated DNA cleavage in human brain tumor cells and human fibroblasts | Q48254621 | ||
| DNA repair endonuclease activity during synchronous growth of diploid human fibroblasts | Q52480216 | ||
| Predominant role for DNA damage in etoposide-induced cytotoxicity and cell cycle perturbation in human SV40-transformed fibroblasts. | Q53533964 | ||
| The role of DNA topoisomerases in recombination and genome stability: a double-edged sword? | Q54710073 | ||
| Need for DNA topoisomerase activity as a swivel for DNA replication for transcription of ribosomal RNA | Q59078548 | ||
| Relationship between the intracellular effects of camptothecin and the inhibition of DNA topoisomerase I in cultured L1210 cells | Q64390367 | ||
| Defective postreplication repair in xeroderma pigmentosum variant fibroblasts | Q67285583 | ||
| The action of caffeine on X-irradiated HeLa cells. I. Delayed inhibition of DNA synthesis | Q67663090 | ||
| Hypersensitivity of cultured ataxia-telangiectasia cells to etoposide | Q68963925 | ||
| Arrest of replication forks by drug-stabilized topoisomerase I-DNA cleavable complexes as a mechanism of cell killing by camptothecin | Q69354693 | ||
| Enhanced expression of X-ray- and UV-induced chromosome aberrations by cytosine arabinoside in ataxia telangiectasia cells | Q69991471 | ||
| Mechanisms of chromosomal aberration production. I. Aberration induction by ultraviolet light | Q70008573 | ||
| Effect of confluent holding on potentially lethal damage repair, cell cycle progression, and chromosomal aberrations in human normal and ataxia-telangiectasia fibroblasts | Q70053984 | ||
| DNA topoisomerases | Q70095180 | ||
| Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I | Q70106083 | ||
| Absence of swiveling at sites of intercalator-induced protein-associated deoxyribonucleic acid strand breaks in mammalian cell nucleoids | Q70814818 | ||
| Mechanisms of inhibition of DNA replication by ultraviolet light in normal human and xeroderma pigmentosum fibroblasts | Q71009312 | ||
| Mitotic delay and repair in human lymphocytes | Q71048640 | ||
| DNA-repair deficiencies do not affect intercalator-induced cytotoxicity or DNA scission in human cells | Q71861168 | ||
| Nonintercalative antitumor drugs interfere with the breakage-reunion reaction of mammalian DNA topoisomerase II | Q72397901 | ||
| Cytogenetic effects of amsacrine on human lymphocytes in vivo and in vitro | Q72738296 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 3711-3718 | |
| P577 | publication date | 1991-07-01 | |
| P1433 | published in | Molecular and Cellular Biology | Q3319478 |
| P1476 | title | Inhibition of replicon initiation in human cells following stabilization of topoisomerase-DNA cleavable complexes | |
| P478 | volume | 11 |
| Q39242603 | Ataxia telangiectasia mutated-dependent regulation of topoisomerase II alpha expression and sensitivity to topoisomerase II inhibitor |
| Q40442271 | Cell cycle checkpoints and DNA repair preserve the stability of the human genome |
| Q40580197 | Cellular radiosensitivity in ataxia-telangiectasia |
| Q30442180 | Chromosome architecture can dictate site-specific initiation of DNA replication in Xenopus egg extracts |
| Q71953379 | Colcemid alters S phase and other parameters in skin during chronic exposure to benzo(a)pyrene |
| Q34249547 | Conversion of normal to malignant phenotype: telomere shortening, telomerase activation, and genomic instability during immortalization of human oral keratinocytes |
| Q24792540 | DNA and the chromosome - varied targets for chemotherapy |
| Q64389076 | DNA signals for G2 checkpoint response in diploid human fibroblasts |
| Q36647845 | DNA strand breaks: the DNA template alterations that trigger p53-dependent DNA damage response pathways |
| Q41078479 | DNA topoisomerase II mutations and resistance to anti-tumor drugs |
| Q41137233 | Damage-sensing mechanisms in human cells after ionizing radiation |
| Q42054523 | Functional interactions of DNA topoisomerases with a human replication origin |
| Q41144438 | Genotoxicity of the laxative drug components emodin, aloe-emodin and danthron in mammalian cells: topoisomerase II mediated? |
| Q36559209 | Human chromosome 3 mediates growth arrest and suppression of apoptosis in microcell hybrids. |
| Q28214430 | Regulation of cellular and SV40 virus origins of replication by Chk1-dependent intrinsic and UVC radiation-induced checkpoints |
| Q36797925 | Regulation of the cell cycle following DNA damage in normal and Ataxia telangiectasia cells |
| Q28534955 | Role of minor groove width and hydration pattern on amsacrine interaction with DNA |
| Q33500497 | The bioavailability of oral GI147211 (GG211), a new topoisomerase I inhibitor |
| Q35950241 | The intra-S-phase checkpoint affects both DNA replication initiation and elongation: single-cell and -DNA fiber analyses |
| Q34061976 | Topoisomerase I-mediated DNA damage |
| Q73784013 | Topoisomerase II cleavable complex formation within DNA loop domains |
| Q28378884 | Topotecan inhibits human immunodeficiency virus type 1 infection through a topoisomerase-independent mechanism in a cell line with altered topoisomerase I |
| Q40852912 | UVB induced cell cycle checkpoints in an early stage human melanoma line, WM35. |
| Q37152060 | Wild-type p53 is a cell cycle checkpoint determinant following irradiation |
| Q41715281 | p53--an acrobat in tumorigenesis |
Search more.